Syndax Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 8.25 M | $192.82 M | 0.19% | 9.53% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 8.05 M | $188.07 M | 0.00% | 9.29% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 5.00 M | $116.72 M | -12.27% | 5.77% |
| STATE STREET CORP | 05/15/2026 | 4.43 M | $103.49 M | -3.62% | 5.11% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 4.25 M | $99.28 M | -9.78% | 4.91% |
| 05/15/2026 | 3.82 M | $89.30 M | 100.00% | 4.41% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 3.78 M | $88.30 M | 100.00% | 4.36% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 2.89 M | $67.41 M | -12.94% | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 05/15/2026 | 2.50 M | $58.40 M | 6.38% | 2.89% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2026 | 2.35 M | $55.00 M | 1.63% | 2.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.16 M | $50.40 M | 3.16% | 2.49% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 2.15 M | $50.23 M | -11.21% | 2.48% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 1.99 M | $46.38 M | -59.33% | 2.29% |
| 05/15/2026 | 1.86 M | $43.33 M | 0.00% | 2.14% | |
| 05/08/2026 | 1.74 M | $40.58 M | 100.00% | 2.01% | |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2026 | 1.73 M | $40.47 M | 25.94% | 2.00% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 1.73 M | $40.34 M | -23.15% | 1.99% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 1.60 M | $37.42 M | 31.35% | 1.85% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.58 M | $36.90 M | 37.72% | 1.82% |
| NUVEEN, LLC | 04/30/2026 | 1.49 M | $34.91 M | 0.79% | 1.73% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 1.34 M | $31.32 M | 0.23% | 1.55% |
| AISLING CAPITAL MANAGEMENT LP | 05/05/2026 | 1.32 M | $30.76 M | 0.00% | 1.52% |
| WOODLINE PARTNERS LP | 05/15/2026 | 1.25 M | $29.22 M | 0.01% | 1.44% |
| STEMPOINT CAPITAL LP | 05/18/2026 | 1.22 M | $28.40 M | -9.23% | 1.40% |
| UBS GROUP AG | 05/05/2026 | 1.15 M | $26.95 M | 61.08% | 1.33% |
| CATALIO CAPITAL MANAGEMENT, LP | 05/15/2026 | 1.04 M | $24.38 M | -12.80% | 1.20% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 1.00 M | $23.47 M | -8.19% | 1.16% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 990.97 K | $23.15 M | -38.01% | 1.14% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 980.31 K | $22.90 M | 5.87% | 1.13% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 962.30 K | $22.48 M | 100.00% | 1.11% |
| ALGERT GLOBAL LLC | 05/14/2026 | 928.57 K | $21.69 M | 0.05% | 1.07% |
| CANDRIAM S.C.A. | 04/30/2026 | 925.33 K | $21.62 M | 0.00% | 1.07% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 901.51 K | $21.06 M | 57.05% | 1.04% |
| MORGAN STANLEY | 05/15/2026 | 893.93 K | $20.88 M | -16.88% | 1.03% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 888.99 K | $20.77 M | 38.28% | 1.03% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 864.99 K | $20.21 M | 8.87% | 1.00% |
| PROSIGHT MANAGEMENT, LP | 05/15/2026 | 770.00 K | $17.99 M | 15.79% | 0.89% |
| NORTHERN TRUST CORP | 05/14/2026 | 755.72 K | $17.65 M | 3.68% | 0.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 724.56 K | $16.93 M | -4.98% | 0.84% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 715.15 K | $16.71 M | -1.69% | 0.83% |
| 05/15/2026 | 701.82 K | $16.39 M | 100.00% | 0.81% | |
| CITADEL ADVISORS LLC | 05/15/2026 | 630.94 K | $14.74 M | 242.90% | 0.73% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 600.52 K | $14.03 M | 100.00% | 0.69% |
| APIS CAPITAL ADVISORS, LLC | 05/15/2026 | 550.00 K | $12.85 M | -24.03% | 0.63% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 498.20 K | $11.64 M | -8.55% | 0.58% |
| KNOTT DAVID M JR | 05/14/2026 | 422.00 K | $9.86 M | 1.69% | 0.49% |
| WALLEYE CAPITAL LLC | 05/13/2026 | 384.97 K | $8.99 M | 1,490.47% | 0.44% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 05/14/2026 | 379.25 K | $8.86 M | -22.13% | 0.44% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2026 | 350.00 K | $8.18 M | 75.00% | 0.40% |
| JANE STREET GROUP, LLC | 05/12/2026 | 335.53 K | $7.84 M | -55.20% | 0.39% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Syndax Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 304 institutional investors and hedge funds held shares of Syndax Pharmaceuticals Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 8.25 M
Kynam Capital Management, LP: 8.05 M
GOLDMAN SACHS GROUP INC: 5 M
STATE STREET CORP: 4.43 M
BANK OF AMERICA CORP /DE/: 4.25 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.78 M
114.71% of Syndax Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 109.14 M shares in the last 24 months. This purchase volume represents approximately $2.61 B in transactions.